ArticleJournal of translational medicine2023
Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia.
Michael Kurnellas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this papertrialcites it